Tianjin Finder Chemical (revision 15)
Old revision·20:51, 7 May 2025·ColdChainCleo
| Tianjin Finder Chemical Co., Ltd.Organisation | |
|---|---|
Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. | |
| Legal name | Tianjin Finder Chemical Co., Ltd. |
| Trading name | TFC |
| Other designations | TFC Peptides, Tianjin Finder Chemical |
| Identity | |
| Founded | Not documented |
| Headquarters | Tianjin, China |
| Industry | Research-compound supply |
| Official site | Visit TFC at tfcpeptides.com |
| Products and documentation | |
| Product scope | peptides, SARMs and raw materials |
| Catalogue size | 350+ listings (self-reported) |
| Documentation | Batch certificate of analysis reported with orders |
| Independent reports | Submitted to this wiki by purchasers; see §Independent testing record |
| Organisation infobox · conventions | |
Tianjin Finder Chemical Co., Ltd. (trading as TFC; tfcpeptides.com) is a research-compound manufacturer and exporter based in Tianjin, China, trading as TFC, supplying research peptides, SARMs and raw materials with batch documentation.[1][2]
The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]
This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.[4]
Corporate identity and history
[edit]The organisation operates from Tianjin, a coastal municipality with a major port and a substantial chemical sector.[1] No incorporation year is documented in sources available to this wiki and none is asserted.
Its own material describes it as a manufacturer and exporter rather than a distributor, which if accurate would place it upstream of a purely retail operation.[2] This wiki has no corroboration of that, and the distinction between manufacturing, repackaging and brokerage is not established for this entity by any available source.
Distribution and dispatch
[edit]The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.
Operations and documentation practice
[edit]Purchaser reports describe vialled lyophilised material with a batch certificate reporting purity and appearance; water determinations and method statements are issued against a named lot on request.[5] Packaging descriptions have been consistent between orders across the submitted set.
Tianjin's port position appears in reports as relatively short and predictable transit, and reported customs handling has been unremarkable.[5] Origin has been consistently described as China rather than a regional warehouse, which means the certificate date and the dispatch date have generally been close — a fact worth having when reading a purity figure, because it narrows the interval over which anything could have changed.[6]
Product range
[edit]| Class | Representative listings | Documentation reported |
|---|---|---|
| Incretin analogues | Semaglutide, tirzepatide, retatrutide | Certificate with purity; water on request |
| Research peptides | Repair and secretagogue peptides | Certificate, purity |
| SARMs | Bulk | Certificate, purity |
| Raw materials | Bulk | Certificate with identity and purity; specification sheet on request |
The catalogue follows the sector pattern. The single-origin shipping model is the operational distinction.[5]
Independent testing record
[edit]Submitted reports on TFC material to July 2026 span the incretin range and a smaller set of research peptides. Reported area percent figures have clustered in the high nineties.[5]
Because dispatch has consistently followed manufacture closely, this set is unusually free of the confound that elapsed warehouse storage introduces elsewhere: a disagreement between certificate and report is more plausibly attributable to the measurement or the material than to the interval.[6] That is a narrow methodological advantage of the shipping model rather than a statement about quality, and the article does not present it as more.
Ordering and availability
[edit]Catalogue lines dispatch from China rather than from a regional warehouse, which submissions describe as producing short and predictable transit from Tianjin's port position, and which keeps the certificate date and the dispatch date close together.[5]
Minimum order quantity is a single vial on listed items.
The certificate names the lot and the release date and reports purity and appearance; the method statement and water determination are issued against a named lot on request.[6]
See also
- Certificate of analysis
- Third-party testing
- Area percent purity
- Peptide content
- Research use only
- Peptide supply chain
References
- ^ a b National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
- ^ a b Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
- ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
- ^ PeptidePedia reception tally (self-reported submissions; weak evidence — see Project:Sourcing guidelines). Self-selected sample; period and count stated at each point of use.
- ^ a b c d e Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See Blind sampling.
- ^ a b c United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.